Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

CF-602 shows promise for sexual dysfunction in preclinical studies

Jan. 28, 2015

FDA awards orphan drug status to Sparsentan for focal segmental glomerulosclerosis

Jan. 13, 2015

Keryx Biopharmaceuticals launches Auryxia in the U.S.

Dec. 24, 2014

Xiapex receives positive opinion by CHMP for Peyronie's disease

Dec. 23, 2014

Taiho Pharmaceutical patents novel compounds for urinary incontinence

Dec. 16, 2014

Phase II data for sotatercept as treatment of anemia in hemodialysis subjects

Dec. 12, 2014

Researchers present phase III clinical data for ZS-9 as treatment of hyperkalemia

Dec. 2, 2014

Kissei Pharmaceutical discloses new TRPM8 antagonists

Nov. 24, 2014

Studies compare time to ESRD in aHUS patients treated with supportive care or eculizumab

Nov. 24, 2014

Kissei Pharmaceutical submits NDA in Japan for PA-21

Nov. 20, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...